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Objectives This study examined the clinical course of patients with asymptomatic severe aortic stenosis (AS) according to
the new proposed aortic valve stenosis grading classification.
Background The management of patients with asymptomatic severe AS remains controversial. Moreover, under the same
denomination of severe AS, several entities might be identified according to transvalvular flow rates and pres-
sure gradients, resulting in 4 flow-gradient patterns.
Methods Transthoracic echocardiography and measurement of B-type natriuretic peptide level from venous blood sample
were performed in 150 consecutive patients with asymptomatic severe AS and normal exercise test. Patients
were classified in 4 groups, depending on left ventricular flow state (normal flow [NF] vs. low flow [LF]: 35 ml/m2)
and pressure gradient levels (low gradient [LG] vs. high gradient [HG]: 40 mm Hg).
Results Patients with NF/LG had significantly lower B-type natriuretic peptide than those with LF/HG and LF/LG. The
mean follow-up was 27  12 months. At 2 years, cardiac event-free survival was 83  6%, 44  6%, 30  12%,
and 27  13% in NF/LG, NF/HG, LF/HG, and LF/LG groups, respectively (p  0.0001). On multivariable analy-
sis, LF/LG (hazard ratio [HR]: 5.26, 95% confidence interval [CI]: 2.04 to 14.3, p  0.045) and LF/HG (HR: 2.38,
95% CI: 1.02 to 5.55, p  0.001) were identified as strong independent determinants of poor prognosis as com-
pared with NF/HG. By limiting the multivariable analysis to patients with LF, LF/LG was an independent predic-
tor of markedly reduced cardiac event-free survival when compared with LF/HG (HR: 5.4, 95% CI: 1.03 to 28.6,
p  0.046).
Conclusions The use of the new proposed AS grading classification integrating valve area and flow-gradient patterns allows a
better characterization of the clinical outcome of patients with asymptomatic severe AS. (J Am Coll Cardiol
2012;59:235–43) © 2012 by the American College of Cardiology Foundation
Published by Elsevier Inc. doi:10.1016/j.jacc.2011.08.072Valvular aortic stenosis (AS) is a growing health problem
with sizeable economic impact. Treatment decisions in AS
are mainly based upon the symptomatic status of the patient
and the severity of AS. Aortic valve replacement (AVR) is
currently indicated in patients with severe AS who develop
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accepted August 9, 2011.symptoms. The management of asymptomatic patients with
severe AS remains a source of debate. In these patients,
recent studies have brought out that early elective surgery
might be more beneficial than medical therapy (1)—namely,
the “wait for symptoms strategy.” This difference might be
related to underestimation of symptoms and/or stenosis sever-
ity in some patients. According to current American College of
Cardiology/American Heart Association guidelines (2), cutoff
See page 244
values for Doppler-echocardiographic measurements of se-
vere AS are defined as follows: aortic valve area (AVA)1.0
cm2, mean gradient 40 mm Hg, and peak velocity 4.0
m/s. However, recent studies have emphasized that the
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are inherently inconsistent, even
in patients with normal left ven-
tricular (LV) systolic function
(3). Under the same denomina-
tion of severe AS, several enti-
ties might be identified that
differ in terms of transvalvular
flow rates and pressure gradients
develop. Hence, from a clinical
standpoint, severe AS (AVA 1
cm2) can be subdivided into 4
flow-gradient patterns. Of note,
this discordance between gradi-
ent and AVA often reflects the
presence of a paradoxical low-
flow (LF) state in which the
stroke volume is unexpectedly re-
duced, despite preserved left ven-
tricular ejection fraction (LVEF)
(4). Such a pattern has been re-
ported in up to 35% of patients
with severe AS and seems to be consistent with a more
advanced stage of the disease (increased global LV afterload,
significant LV concentric remodeling, and intrinsic myocar-
dial dysfunction) (4). Misinterpreting this clinical condition
might lead to an inappropriate timing of follow-up with an
unnecessary delay of AVR. In asymptomatic patients, risk
stratification has been mostly evaluated in patients with a
normal flow (NF)/high gradient (HG) pattern (5). In this
group, the severity of stenosis, the degree of aortic valve
calcification, the rate of progression of stenosis, the level of
B-type natriuretic peptide (BNP), and an abnormal re-
sponse to exercise have been shown to be associated with a
poorer prognosis (6–9). By contrast, in the other AS
categories, the outcome has never been specifically exam-
ined. Therefore, we prospectively studied the clinical course
of a large cohort of consecutive patients with asymptomatic
severe AS according to the new proposed AS grading
classification.
Methods
We prospectively included consecutive patients with asymp-
tomatic severe AS, defined as an AVA 1 cm2, referred to
our outpatient clinic for valvular heart disease for an exercise
test and a BNP measurement. Only patients with normal
exercise test (no symptoms, normal blood pressure evolu-
tion, and no ventricular arrhythmias during the test) were
considered for the final analysis of the study. The other
exclusion criteria were: 1) LVEF 55%; 2) more than mild
concomitant valvular heart disease; 3) atrial fibrillation;
4) pulmonary disease; and 5) inability to perform exercise
test. The final studied population consisted of 150 patients
Abbreviations
and Acronyms
AS  aortic stenosis
AVA  aortic valve area
AVR  aortic valve
replacement
BNP  B-type natriuretic
peptide
CI  confidence interval
HG  high gradient
HR  hazard ratio
LA  left atrial
LF  low flow
LG  low gradient
LV  left ventricle/
ventricular
LVEF  left ventricular
ejection fraction
NF  normal flow(age 69.7  8 years, 64% men). The collection of baseline bdemographic and clinical data was standardized and per-
formed at the time of echocardiography.
Echocardiographic study. A comprehensive transtho-
racic echocardiography was performed with the VIVID 7
ultrasound system (General Electric Healthcare, Little
Chalfont, United Kingdom) in all patients. All Doppler-
echocardiographic recordings were stored in digital for-
mat on a dedicated workstation for offline subsequent
analysis. All echocardiographic measurement were per-
formed as previously described by our group (6,8). Of
note, LV stroke volume was calculated with both the
Doppler (LV outflow tract area  LV outflow tract
velocity–time integral measured by pulsed-wave Doppler)
and the volumetric (bi-apical Simpson’s method) meth-
ods. Moreover, multiple transducer positions were used
to record peak aortic jet velocities. The highest transaor-
tic velocity was used for tracing of the time-velocity
integral and to calculate pressure gradients. For each
measurement, at least 2 cardiac cycles were averaged.
BNP measurement and risk score. Venous blood samples
for BNP measurement were drawn before echocardiogra-
phy, after 10 min of supine rest. Chilled ethylenedi-
aminetetraacetic acid tubes were centrifuged immediately at
4,000 rpm (4°C) for 15 min. Separated plasma samples were
processed by immunofluorescence assay (Biosite, Beckman
Coulter, San Diego, California). The inter- and intra-assay
variation was 5% and 4%, respectively. The assay detection
limit was 1 pg/ml. A predictive risk score—including BNP,
sex, and aortic valve peak velocity—was calculated for each
patient according to the recent work of Monin et al. (9). This
score integrates the complex interplay between the aortic valve
and the LV. It was validated in a multicenter study including
patients with asymptomatic moderate-to-severe AS and was
identified as useful for risk stratification of such patients.
Event-free survival. Follow-up information was obtained
every 6 to 12 months from standardized interviews with the
patients, their physicians, or (if necessary) next of kin, accord-
ing to guidelines (2,10). The primary outcome variable was the
time to occurrence of the first composite endpoint, defined as
cardiovascular death or need for AVR motivated by the
development of symptoms or LV systolic dysfunction (LVEF
50%). The clinical management of the patients was deter-
mined independently by their personal physicians.
New proposed AS grading classification. Patient out-
come was studied according to the new proposed AS
grading classification (4). Patients were classified in 4 groups
depending on LV flow state (NF vs. LF) and pressure
gradient level (low gradient [LG] vs. HG). As previously
described, LF was defined as an indexed LV stroke volume
35 ml/m2 (4), and LG was defined as a mean transaortic
ressure gradient 40 mm Hg (11). This classification
esults in the following 4 flow-gradient patterns: NF/LG,
F/HG, LF/HG, and LF/LG.
tatistical analysis. Results are expressed as mean SD or
ercentage unless otherwise specified. Data comparisons
etween patients developing a predefined event and those
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chi-square test, or Fisher exact test, as appropriate. Data of
the 4 flow-gradient AS groups were compared for statistical
significance with 1-way analysis of variance and then with a
Tukey test. The BNP levels were compared between groups,
due to normality test failure (Kolmogorov-Smirnov), with
Kruskal-Wallis 1-way analysis of variance on ranks and then
with a Dunn’s test.
Probabilities of event-free survival were obtained by
Kaplan-Meier estimates for the 4 AS groups and then
compared by the use of a 2-sided log-rank test. The impact
of group classification on event-free survival was assessed
with Cox proportional-hazards models in univariable and
multivariable analyses. Variables with a univariable value of
p  0.10 were incorporated into the multivariable models.
The selection of variables included in the multivariate model
was performed with a special care. To avoid colinearity
among a subset of several variables measuring the same
phenomenon (e.g., AVA, peak gradient, mean gradient), we
entered in the multivariate models the variable that had
the strongest association with event-free survival on univari-
able analysis. The group classification was entered into the
model, and patients with NF and LG (i.e., those expected as
having the better outcome) were considered as referent. We
also built another multivariable model including the risk
score (9). Because this score comprises BNP level and peak
aortic velocity, these 2 variables were removed from the final
statistical model. Values of p  0.05 were considered
statistically significant. All statistical analyses were per-
formed with STATISTICA (version 6, StatSoft Inc., Tulsa,
Oklahoma). The authors had full access to and take full
responsibility for the integrity of the data. All authors have
read and agree to the manuscript as written.
Results
Characteristics of the patients. Demographic and clinical
Demographic and Clinical Data (N  150)Table 1 Demographic and Clinical Data (N  150)
Demographic
Age, yrs 69.7 8.0
Male 96 (64)
Body surface area, m2 1.82 0.2
Hemodynamic status
Systolic arterial pressure, mm Hg 143 21
Diastolic arterial pressure, mm Hg 77 11
Heart rate, beats/min 71 12
Risk factors
Hypertension 87 (58)
Obesity 47 (31)
Hypercholesterolemia 74 (49)
Diabetes 23 (15)
Smoking 45 (30)
Left ventricular hypertrophy 83 (55)
Left bundle branch block 18 (12)
Values are mean  SD or n (%).data are reported in Table 1. On echocardiographic analysis,all patients had moderate-to-severe aortic valve calcification.
The mean indexed AVA was 0.5 0.11 cm2/m2. The mean
LV outflow tract stroke volume was 85.8 21.5 ml and was
widely ranging from 37 to 148 ml. According to the new
proposed AS grading classification defined in Methods,
NF/HG was found in 78 patients (52%), NF/LG was found
in 46 (31%) patients, LF/HG was found in 15 (10%)
patients, and LF/LG was found in 11 (7%) patients.
Patients with NF/LG had significantly lower BNP than
those with LF/HG and LF/LG (Fig. 1) and lower mid-
term mortality risk score (Monin et al. [9] score) than the 3
other groups (Table 2). In addition, patients in NF/HG had
significant lower BNP level than those of the LF/HG group
(Fig. 1). Demographic, echocardiographic, and clinical char-
acteristics of the 4 groups are reported in Table 2. By design,
all patients had a severe AS defined as an AVA 1 cm2
(maximal AVA in each group: NF/LG: 0.98 cm2, NF/HG:
0.97 cm2, LF/HG: 0.96 cm2, and LF/LG: 0.98 cm2).
In the whole cohort, LV global longitudinal strain was
egatively correlated with valvulo-arterial impedance (r 
0.23, p  0.005). This relationship was better in the
F/HG group (r  0.33, p  0.004) and in the LF/HG
roup (r  0.61, p  0.017). There was no significant
orrelation between LVEF and valvulo-arterial impedance in the
hole cohort (p  0.87) or in any AS category (p  0.50).
linical outcomes. The follow-up was complete in all
atients (100%). The mean follow-up time was 27  12
onths (median: 26 months, range: 2 to 48 months).
uring follow-up, 76 patients (51%) fulfilled the predefined
ndpoint, resulting in event-free survival of 71  4%, 51 
%, and 40  5% at 1-, 2- and 3-year follow-up, respec-
ively (Fig. 2). A total of 9 patients died during the
ollow-up. The cause of death was cardiac in 8 patients. A
Figure 1
Box-Plot of Brain Natriuretic Peptide Level
According to the New Proposed Classification
of Aortic Stenosis
The numbers under each box are median (25% to 75%). *Significant differ-
ences with normal flow (NF)/low gradient (LG) group (p  0.05); †significant
differences with NF/high gradient (HG). LF  low flow.
ular; LV
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be asymptomatic at the last examination performed within 6
months before death. The reasons for the other 5 cardiac
deaths were congestive heart failure. Of note, 2 patients died
in the postoperative period of AVR. During follow-up,
Comparison of Demographic, Echocardiographic, and Clinical DataAccording to the New Proposed AS Grading ClassificationTable 2 Comparison f Demograph c, Echo ardiographic, and CAccording to the New Proposed AS Grading Classificat
NF/LG
(n  46) (31%) (
Age, yrs 69 8
Male, % 29 (63)
Body surface area, m2 1.8 0.2
AVA, cm2 0.85 0.08
Indexed AVA, cm2/m2 0.47 0.07
Peak aortic velocity, m/s1 3.5 0.4
Mean aortic gradient, mm Hg 32 5
Valvulo-arterial impedance, mm Hg/ml/m2 3.7 0.8
LVEDV index, ml/m2 58 14
LVESV index, ml/m2 21 7
LV stroke volume, ml 74 16
Indexed LV stroke volume, ml/m2 41 10
LVEF, % 67 8
LV longitudinal strain, % 16.7 2.6
LA area index, cm/m2 12.4 4.0
BNP, pg/ml 34 5
Risk score 12.2 2.0
Values are mean  SD. *Significant difference (p  0.05) with normal flow (NF)/low gradient (L
(LF)/HG group.
AS  AS; AVA  aortic valve area; BNP, brain natriuretic peptide; LA, left atrial; LV  left ventric
ventricular end-systolic volume.
Figure 2 Adjusted Incidence of Cardiac Events According to th
The adjustment was performed as in the multivariate model reported in Table 4. Psurgery was indicated in accordance with the guidelines in
70 patients for the following reasons: development of
symptoms (n  58), rapid hemodynamic progression (n 
2), positive exercise test (n 8), and reduced left ventricular
function (n  2). Three of these patients were awaiting
al Data
/HG
8) (52%)
LF/HG
(n  15) (10%)
LF/LG
(n  11) (7%) p Value
 10 71 8 65 14 NS
(68) 9 (60) 5 (45) NS
 0.2 1.9 0.2 1.8 0.2 NS
 0.1 0.74 0.15* 0.80 0.14 0.04
 0.08 0.39 0.09* 0.45 0.09 0.04
 0.6* 4.6 0.4* 3.8 0.5†‡ 0.0001
 12* 50 14* 33 5†‡ 0.0001
 0.9 5.9 1.1*† 6.0 1.1*† 0.0001
 18 55 14 52 16 NS
 12 20 11 19 12 NS
 16 63 7*† 59 10*† 0.003
 11 33 2*† 31 2*† 0.0001
 7.5 66 7 66 8 NS
 2.6 14.8 2.7* 13.6 4.3*† 0.002
 3.0 13.4 3.0 13.0 3.0 NS
 10 110 14*† 95 18* 0.0001
 2.0* 16.5 2.0* 14.9 2.0* 0.0001
p; †significant difference with NF/high gradient (HG) group; ‡significant difference with low flow
EDV  left ventricular end-diastolic volume, LVEF  left ventricular ejection fraction; LVESV  left
w Proposed Classification of Aortic Stenosis
tient; other abbreviations as in Figure 1.linic
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January 17, 2012:235–43 Aortic Stenosis Grading ClassificationAVR at the time of the current follow-up but were analyzed
as patients having undergone AVR.
According to the new proposed AS grading classification,
the 2-year cardiac event-free survival was 83  6%, 44  6%,
30 12%, and 27 13% in NF/LG, NF/HG, LF/HG, and
LF/LG groups, respectively (p  0.0001).
Baseline event-free survival predictors. Compared with
patients remaining free from event (Table 3), those devel-
oping cardiac events had significantly more severe AS and
higher valvulo-arterial impedance. They also had statisti-
cally higher LV end-diastolic volume, mitral A wave and
indexed left atrial (LA) area (p  0.0001), and lower LV
longitudinal strain. By contrast, there was no significant
difference between groups for LV end-systolic volume, mass
and ejection fraction, mitral E wave, E/A, and E/Ea ratios.
Of note, there was no significant difference in event-free
survival according to the tertiles of LVEF (tertile 1: 55% to
61%, tertile 2: 62% to 70%, tertile 3: 71% to 85%; p 0.90).
Univariable Cox proportional hazard model (Table 4)
showed that AS severity parameters, valvulo-arterial imped-
ance, LV volumes and longitudinal strain, mitral A wave,
indexed LA area, and BNP were significantly associated
with event-free survival. In addition, compared with pa-
tients with NF/LG (referent), those with LF/LG had a
worse outcome (hazard ratio [HR]: 4.54, 95% confidence
interval [CI]: 1.99 to 11.1, p  0.001). Patients with
LF/HG also tended to have lower cardiac event-free sur-
vival than NF/LG group.
On multivariable analysis, after adjustment for univari-
able predictive factors, peak aortic velocity (HR: 1.7, 95%
CI: 1.04 to 2.84, p 0.035), LV end-diastolic volume (HR:
1.01, 95% CI: 1.01 to 1.02, p  0.002), and indexed LA
area (HR: 1.13, 95% CI: 1.06 to 1.2, p  0.0001) were
Echocardiographic Data According to the OccurTable 3 Echocardiographic Data According
Variables
All Pat
(n 
AS severity
Indexed AVA, cm2/ m2 0.45
Peak aortic velocity, m/s 4.13
Mean pressure gradient, mm Hg 44.6
LV global afterload
Valvulo-arterial impedance, mm Hg/ml/m2 4.17
LV mass, g/m2 194.5
LV function
LVEDV, ml 100.5
LVESV, ml 35.2
LVEF, % 66.6
LV longitudinal strain, % 16.1
Mitral E wave, m/s 0.80
Mitral A wave, m/s 0.95
Mitral E/A ratio 0.89
Mitral E/Ea ratio 10.8
LA geometry
LA area index, cm2/m2 12.3Abbreviations as in Table 2.independently associated with event-free survival. More-
over, in the same multivariable model, the new proposed AS
grading classification according to flow and gradient was
also an independent predictor of event-free survival (p 
.009) (Fig. 2). The LF/LG (HR: 5.26, 95% CI: 2.04 to
4.3, p  0.045) and LF/HG (HR: 2.38, 95% CI: 1.02 to
.55, p  0.001) were identified as strong independent
eterminants of poor prognosis as compared with NF/LG
Table 4). Interestingly, when adding the risk score in the
odel, the new proposed AS grading classification re-
ained independently associated with outcome (p  0.03).
n this model, the risk score was significantly associated
ith the occurrence of cardiac event (HR: 1.21, 95% CI:
.05 to 1.4, p  0.009).
In multivariable analysis, “LF” alone was independently
ssociated with reduced cardiac event-free survival (HR:
.8, 95% CI: 1.08 to 3.1, p  0.024). In the same model,
xcluding “LF” variable, “LG” was also an independent
redictor of reduced cardiac event-free survival (HR: 2.4,
5% CI: 1.4 to 4.2, p  0.003). Finally, when we added the
variables in the model, both “LF” and “LG” emerged as
ndependent predictors (HR: 1.7, 95% CI: 1.01 to 2.9, p 
.046; HR: 2.3, 95% CI: 1.3 to 4.0, p 0.004, respectively).
e also found similar results when the variables were
ncluded in a continuous format (i.e., indexed LV stroke
olume and mean pressure gradient).
Furthermore, in a multivariable model, limited to patients
ith LF, LF/LG was an independent predictor of low
ardiac event-free survival when compared with LF/HG
HR: 5.4, 95% CI: 1.03 to 28.6, p 0.046). Similarly, when
ompared with the NF/HG group (i.e., the more prevalent
ubgroup of severe AS) in multivariable analysis, LF/LG
of Eventse Occurrence of Events
No Event
(n  74) (49%)
Events
(n  76) (51%) p Value
0.46 0.08 0.43 0.08 0.04
3.89 0.60 4.37 0.67 0.0001
40.2 12.7 48.8 14.7 0.0001
3.91 0.88 4.43 1.37 0.007
187.6 89.1 202.9 89.4 0.35
92.8 29.2 108.0 34.9 0.004
32.7 16.5 37.6 20.6 0.11
66.4 7.7 66.7 7.6 0.225
16.5 2.4 15.6 2.8 0.035
0.78 0.24 0.82 0.24 0.24
0.89 0.27 1.01 0.36 0.035
0.90 0.29 0.88 0.40 0.71
10.3 3.5 11.3 4.8 0.13
10.8 3.0 13.7 2.9 0.0001renceto th
ients
150)
0.08
0.70
14.3
1.18
89.2
32.9
18.8
7.6
2.6
0.24
0.32
0.35
4.2
3.3
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Aortic Stenosis Grading Classification January 17, 2012:235–43remained significantly associated with increased risk of
cardiac events (HR: 4.3, 95% CI: 2.01 to 13.9, p  0.001).
Discussion
Under the terminology of severe AS, several flow-gradient
patterns might be identified. The present study shows for the
first time that the clinical outcome of truly asymptomatic
patients (normal exercise test) with severe AS (AVA 1 cm2)
aries noticeably according to these flow-gradient relation-
hips. As compared with the other AS categories, patients with
F/LG have a better cardiac event-free survival. Conversely,
oth LF/LG and LF/HG entities are associated with a poorer
utcome. Finally, patients with NF/HG, the expected pattern
or severe AS, present an intermediate prognosis when com-
ared with the other groups.
ew proposed AS grading classification and outcome.
NF/LG. This pattern is characterized by a lower than
xpected mean aortic pressure gradient (i.e., 40 mm
Univariable and Multivariable Cox Proportional HTable 4 Univariable and Multivariable Cox P
Variables
Univari
HR 95% C
Demographic and clinical data
Age 1.01 0.98–1.0
Male 0.89 0.56–1.4
Hypertension 1.40 0.89–2.2
Obesity 1.16 0.72–1.8
Hypercholesterolemia 1.04 0.67–1.6
Diabetes 0.88 0.46–1.6
Smoking 1.05 0.70–1.5
LV hypertrophy 0.70 0.43–1.1
AS severity
Indexed AVA 0.09 0.01–0.7
Peak aortic velocity 2.07 1.47–2.9
Mean pressure gradient 1.026 1.01–1.0
LV global afterload
Valvulo-arterial impedance 1.20 1.04–1.4
LV mass 1.002 0.99–1.0
LV function
LV end-diastolic volume 1.01 1.01–1.0
LV end-systolic volume 1.01 0.99–1.0
LVEF 1.003 0.97–1.0
LV longitudinal strain 1.12 1.02–1.2
Mitral E-wave 1.65 0.67–4.0
Mitral A-wave 2.55 1.24–5.
Mitral E/A ratio 0.84 0.40–1.
Mitral E/Ea ratio 1.02 0.97–1.
LA geometry
LA area index 1.10 1.05–1.
Brain natriuretic peptide 1.004 1.00–1.
New proposed classification
NF/LG (referent) 1.00 1.00–1.
NF/HG 1.01 0.42–2.
LF/HG 1.51 0.74–3.
LF/LG 4.54 1.99–11
CI  confidence interval; HR  hazard ratio; other abbreviations as ing). In the present study, patients with NF/LG exhib-ted the best prognosis. This entity is relatively frequent
31%) and characterized by a preserved LV longitudinal
yocardial function, resulting in lower BNP level (Fig. 1)
nd risk score. In this group, the 3-year cardiac event-free
urvival was 66  9%, which was consistent with the
vent rate reported in patients with an aortic jet velocity
4.5 m/s (5,8,9). These results suggest that NF/LG
attern identifies a group of patients with a less-severe
egree of AS or who has been exposed to the disease for
shorter period of time. Of note, the LA index, a marker
eflecting the chronicity of diastolic burden, was lower in
hese patients. The LA size, when increased, represents a
trong independent predictor of outcome in asymptom-
tic moderate-to-severe AS (8).
NF/HG. This pattern is characterized, as expected, by a
mean aortic pressure gradient 40 mm Hg. It represents
the most prevalent entity in our series of patients (52%).
The 3-year cardiac event-free survival rate of NF/HG, when
d Analysisrtional Hazard Analysis
Multivariable
p Value HR 95% CI p Value
0.65 — — —
0.64 — — —
0.16 — — —
0.53 — — —
0.88 — — —
0.70 — — —
0.82 — — —
0.18 — — —
0.027 — — —
0.0001 1.82 1.13–2.90 0.013
0.0001 — — —
0.018 — — —
0.19 — — —
0.007 1.01 1.01–1.02 0.003
0.085 1.01 0.98–1.03 0.54
0.86 — — —
0.013 1.06 0.96–1.17 0.23
0.27 — — —
0.011 1.33 0.62–2.84 0.46
0.65 — — —
0.40 — — —
0.0001 1.13 1.06–1.20 0.0001
0.0001 — — —
NA 1.00 1.00–1.00 NA
0.38 2.12 0.80–5.83 0.14
0.08 2.24 1.02–5.47 0.043
0.001 5.22 2.02–14.1 0.001
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apparent similar impact of AS on LV longitudinal function
and left atrium in both groups (NF/LG and NF/HG), the
NF/HG pattern probably corresponds to patients at a more
advanced stage of the disease. This assumption is corrobo-
rated by the higher BNP level (Fig. 1) and risk score in this
category. Furthermore, patients with NF/HG seem to have
more severe AS, suggesting a longer exposure to this
progressive disease. Given the high prevalence of this entity
in asymptomatic severe AS and the relatively high event
rate, despite preserved LV systolic function, the manage-
ment of these patients underlines the need for optimized
risk stratification.
LF/HG. In the present study, 15% of our patients had a
F/HG pattern. By definition, these patients have an
ndexed LV stroke volume 35 ml/m2 in spite of preserved
VEF. In AS, it is well-known that LVEF is a crude
stimate of LV systolic function. It might remain normal,
espite the presence of reduced LV long-axis function. In
symptomatic patients with AS, impaired subendocardial
unction has been shown to be associated with impaired
xercise tolerance and poor prognosis (12,13). Our results
xtend these preliminary data (8). A reduction in LV
ongitudinal deformation was, however, mostly observed in
he LF/HG category. Of note, this pattern was also char-
cterized by higher BNP level (Fig. 1) and risk score. As
ompared with NF/LG, LF/HG was independently asso-
iated with a more than 2-fold increased risk of cardiac
vents. The 3-year cardiac event-free survival was low (20
1%) but nearly identical to that of patients with NF/HG,
ven though their BNP and risk scores were higher. These
ata indicate that the LV afterload burden is likely superior
o that suggested by the LVEF. In this LF/HG group, the
F state can thus represent a marker of the presence of
ntrinsic myocardial dysfunction. Careful risk stratification
emains the clue in these patients, who deserve an accurate
ssessment of LV regional function.
LF/LG. An LF/LG pattern was observed in 7% of our
atients. It is characterized by a mean aortic pressure
radient 40 mm Hg, an indexed LV stroke volume 35
l/m2, a preserved LVEF, and an AVA 1 cm2. This
attern, namely paradoxical LF AS, represents a challenging
linical entity that has been recently emphasized. It is
ssociated with more pronounced LV concentric remodel-
ng, smaller LV cavity, increased global LV afterload,
ntrinsic myocardial dysfunction, and a dismal prognosis (4).
ur data are roughly in line with these previous results. The
ower prevalence of LF/LG in our series likely relates to the
nclusion of patients with a negative exercise test (i.e., “truly”
symptomatic). This LF/LG category displayed the worse
utcome. The likelihood of remaining alive without AVR at
years was 5-fold lower than for the NF/LG pattern.
urthermore, the risk of cardiac events was 4.3-fold higher
n the LF/LG category than in the NF/HG group (i.e., the
ost prevalent entity of severe AS). The majority of events occurred during the first 24 months. Of note, patients with
F/LG have a cluster of findings, suggesting that they are
ikely at a more advanced stage of their disease. This LF
attern was in fact associated with higher BNP level and
ore pronounced impairment of LV longitudinal myocar-
ial function as compared with NF pattern. Interestingly,
espite markedly lower event-free survival, patients in
F/LG group exhibit slightly lower BNP and thus risk
core than patients with either LF/HG or NF/HG (Fig. 1,
able 2). This observation emphasizes that risk scores
ight fail to predict the actual risk on an individual basis.
urthermore, our results suggest that the risk score pro-
osed by Monin et al. (9) should be interpreted with caution
n patients with LF/LG AS. Conversely, it remains an
ccurate tool to stratify the risk in the other 3 entities. Of
ote, in LF/LG AS, the peak aortic jet velocity is by
efinition reduced (flow-dependent parameter), resulting in
lower risk score, despite elevated BNP levels. This
mphasizes the need for further studies aiming at identify-
ng better predictors of outcome of the patients with
F/LG AS. Of note, the relative reduction in BNP level in
he LF/LG group might be related to exhausted BNP
roduction (longstanding exposition to the disease), higher
NP clearance, or diminished BNP release secondary to
educed LV wall stress (lower LV volumes than for LF/HG
roup).
Previous studies have shown that patients with LF/LG
re less frequently referred to surgery than those with
F/HG, probably due to underestimation of stenosis se-
erity in light of the relatively low gradient. Hence, failure
o recognize this entity can lead to misdiagnosis and
nappropriate decision making. The main source of error
elates, practically, to the miscalculation of LV stroke
olume. In the present study, evidence of an LF state was
onfirmed by concordant LV stroke volume with both the
oppler and the volumetric methods. Recently, the results
f a post-hoc analysis of the Simvastatin and Ezetimibe in
ortic Stenosis trial concerning patients with LG severe AS
nd moderate AS have been reported (14). Prevalence and
utcome of LG and LF/LG significantly differ between our
tudy and the article by Jander et al. (14). Several findings
ight explain such discrepancies—the most important be-
ng the misclassification of the grade of AS. There are
everal potential causes of discordance between AVA and
radient in patients with preserved LVEF, including:
) measurement errors; 2) small body size; 3) paradoxical LF
S; and 4) inconsistent grading related to intrinsic discrep-
ncies in guidelines criteria. First, patients with small body
ize and LV dimensions might exhibit a lower transvalvular
ressure gradient, because of a lower albeit normal stroke
olume. In contrast to findings of the study by Jander et al.
14) (lower values of body surface area in patients with LG),
he body surface area was similar between groups in our
opulation. Second, the stroke volume and therefore the
VA might be underestimated because of underestimation
f LV outflow tract and/or misplacement of pulsed-wave
n
i
r
d
s
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both the volumetric method and the LV outflow-tract
derived stroke volumes were discordant in the study by
Jander et al. (14). Moreover, when indexed to body surface
area, LV stroke volume indexes were almost similar in both
groups (42.1 ml/m2 vs. 42.8 ml/m2), suggesting that a large
umber of patients with LG severe AS had a stroke volume
ndex 35 ml/m2 and thus an NF. Finally, when AVA was
ecalculated with the newly obtained LV stroke volume (i.e.,
erived from the volumetric method), both groups had
imilar AVA (LG severe AS: 0.99 cm2; moderate AS: 1.01
cm2). These discrepant data and the high rate of misclassi-
fications probably explained the similar outcome between
groups in the study of Jander et al. (14).
Clinical implications. The results of the present study
strengthen the need for a more comprehensive evaluation of
AS severity by integrating the flow-gradient pattern into the
classic measurement of AVA. Even if they are “really”
asymptomatic, the clinical outcomes of these patients vary
substantially between categories. The NF/LG pattern was
associated with the best prognosis. Of note, no patient of
this group died during follow-up. Furthermore, the risk/
benefit ratio seems to be largely in favor of treating these
patients medically. Conversely, the likelihood of remaining
free of events decreased significantly in the 3 other catego-
ries—the worse outcome being observed in the LF/LG
group. This latter pattern might bring some uncertainty
about the actual severity of AS and might lead clinicians to
erroneously conclude that the stenosis is not severe and thus
to inappropriate delay of follow-up. Practically, these pa-
tients deserve closer follow-up (every 6 months) and might
benefit from complementary investigation (BNP level mon-
itoring, exercise echocardiography, calcium score measure-
ment). Early elective AVR could represent a beneficial
option in those with low comorbidities. Recently, Kang et
al. (1) reported that, compared with the conventional
approach (i.e., wait for symptoms), early surgery in patients
with asymptomatic AS and preserved LVEF was associated
with better postoperative LV mass improvement, lower
occurrence of postoperative LV dysfunction, and higher
long-term survival, essentially by decreasing cardiac mortal-
ity (1). Hence, the authors promote early surgery in patients
with low operative risk. Indeed, the main concern relates to
the possibility of irreversible myocardial damage if inappro-
priately treated. Patients with an HG pattern displayed an
intermediate outcome, regardless of the flow state. However,
the LF state represents a witness of intrinsic myocardial
dysfunction. Careful assessment of LV function with advanced
echocardiographic parameters (i.e., 2-dimensional strain imag-
ing) and appropriate risk stratification is the key in this context.
In our study, the values of BNP and risk score are limited,
because they can be considered in a “grey zone.” Conversely,
exercise echocardiography could potentially be of interest,
specifically if it shows a significant rise in mean aortic pressure
gradient (15).Study limitations. The major limitation of the present
study relates to the small number of patients in both LF
categories, particularly in LF/LG group. This emphasizes
the low frequency of such patients in the asymptomatic
severe AS population. However, the prevalence of each
entity of AS reported in the present study should not be
compared with other studies including both asymptomatic
and symptomatic patients.
Apparent nonsignificant association between LF groups
and echocardiographic or clinical parameters might be
related to type II error due to the small sample size.
Nonetheless, this limitation does not affect the validity of
the main results of this study.
The absence of evaluation of the presence and extent of
coronary artery disease in patients not referred to surgery is
also a limitation of this report. However, these patients
have, by definition, no symptoms and normal LVEF and
exercise test. In this context, coronary angiography is not
recommended.
Conclusions
The use of the new proposed AS grading classification,
integrating valve area and flow-gradient patterns, allows a
better characterization of the clinical outcome of patients
with asymptomatic severe AS.
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